Last updated: April 18, 2024
Sponsor: San Diego State University
Overall Status: Active - Recruiting
Phase
N/A
Condition
Bone Diseases
Metabolic Disorders
Treatment
Prune
Clinical Study ID
NCT06184646
HS-2023-0243
Female
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- Postmenopausal
- BMD t-score is between 0.5 and 2 SD below the mean
- Not on hormone replacement therapy (HRT) and/or other pharmacological agents known toaffect bone for at least three months prior to initiation of the study
Exclusion
Exclusion Criteria:
- Women whose BMD t-score at any site falls below 2.5 SD of the mean
- Subjects receiving endocrine (e.g., prednisone, other glucocorticoids) or neuroactive (e.g., dilantin, phenobarbital) drugs or any drugs known to influence bone and calciummetabolism
- Subjects who smoke cigarettes or vape
- Regular consumption of dried plum or prune juice
Study Design
Total Participants: 200
Treatment Group(s): 1
Primary Treatment: Prune
Phase:
Study Start date:
March 15, 2024
Estimated Completion Date:
December 31, 2028
Study Description
Connect with a study center
San Diego State University
San Diego, California 92182-7251
United StatesActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.